Furthermore, we examine the impact of cancer-associated point mutations in the Baz2B BRD, which destabilize the bromodomain, induce conformational changes, and lead to the loss or even a switch in acetylated H3 peptide binding affinity. This evidence concerns the gene BAZ2B and cancer.